BioElectronics Announces FDA Market Clearance for Over-The-Counter Treatment of Musculoskeletal Pain

FREDERICK, MD- February 3, 2020 – BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com, the maker of non-invasive electroceutical devices, is pleased to announce that it has obtained a new 510(k) clearance from the U.S. Food and Drug Administration (FDA).  This new, over-the counter marketing clearance was granted for the drug free ActiPatch® medical device, for the … Continue Reading